Natco Pharma has received successful Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for the inspection conducted, during the period February 8 - February 12, 2016, at its Chemical Division, Chennai, India (named Natco Organics, prior to amalgamation into the company).
The company has recently received successful EIR during the period February 29 to March 7, 2016 from the USFDA for the inspection conducted at its drug manufacturing facility in Kothur Village, Mahaboob Nagar District, Telangana.
Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.
